Houte Hans van
Chief Financial Officer · Nurix Therapeutics, Inc.
- 2024
- Aug 5, 2026
- 12
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Houte Hans van files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Christine Ring - $3.33M in NRIX purchases and sales in the last 12 months
- Gwenn Hansen - $522K in NRIX purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Houte Hans van?
Houte Hans van is a corporate insider, tracked as Chief Financial Officer of Nurix Therapeutics, Inc. (NRIX). InsiderAlpha holds 12 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Houte Hans van submitted recently?
2 primary Form 4 filings in the last 90 days, covering 1 company.
Has Houte Hans van been buying or selling stock?
Recorded transactions: 0 open-market purchases and 14 open-market sales ($890K) across all tracked filings.
